Clinical Trial Update: The Effects of Sacubitril/Valsartan on Cardiac Oxygen Consumption and Efficiency of Cardiac Work in Heart Failure Patients [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluated the effects of Sacubitril/Valsartan on cardiac oxygen consumption and efficiency of cardiac work in patients with heart failure; resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Sacubitril/Valsartan (sacubitril/valsartan)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Heart Failure | Phase 4 | Status: COMPLETED | Results posted: 2024-01-05